|
7SD0
Cryo-EM structure of the SHOC2:PP1C:MRAS complex
提交 2021-09-29
|
聚集状态不同
配体/离子不同
实验方法不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
2–582(581 aa)
|
未记录
|
GCP PHOSPHOMETHYLPHOSPHONIC ACID GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
MN MANGANESE (II) ION × 2
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.5
cryo-EM玻璃化条件
冷冻剂 ETHANE;Used the "perpetually hydrated" method of applying graphene oxide. (Cheung et al., 2018)
|
分辨率 2.95 Å
|
|
7T7A
Crystal Structure of Human SHOC2: A Leucine-Rich Repeat Protein
提交 2021-12-14
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
88–581(494 aa)
|
未记录
|
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;281 K;400 mM magnesium nitrate
200 mM Tris PH 8.5
23-30% PEG 4K
|
分辨率 1.79 Å
R-free 0.241
|
|
7T7A
Crystal Structure of Human SHOC2: A Leucine-Rich Repeat Protein
提交 2021-12-14
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 B
88–581(494 aa)
|
未记录
|
NO3 NITRATE ION × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;281 K;400 mM magnesium nitrate
200 mM Tris PH 8.5
23-30% PEG 4K
|
分辨率 1.79 Å
R-free 0.241
|
|
7TVF
Crystal structure of the SHOC2-MRAS-PP1CA (SMP) complex to a resolution of 2.17 Angstrom
提交 2022-02-04
|
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 D
2–582(581 aa)
|
未记录
|
GOL GLYCEROL × 7
SO4 SULFATE ION × 5
MN MANGANESE (II) ION × 2
NA SODIUM ION × 2
PO4 PHOSPHATE ION × 1
CL CHLORIDE ION × 2
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293.15 K;Crystals originally grown in 15% PEG 1500, 0.1M MIB pH 4.2 (15mg/ml of SMP) were used to make seeds. Microseeded into a condition with a reservoir consisting of 17.8% PEG 3350, 136mM sodium sulfate with 1:10 dilution of seeds (7.5mg/ml of SMP) using a ratio of 200nl protein:133nl reservoir:67nl diluted seeds
|
分辨率 2.17 Å
R-free 0.226
|
|
7TVF
Crystal structure of the SHOC2-MRAS-PP1CA (SMP) complex to a resolution of 2.17 Angstrom
提交 2022-02-04
|
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
2–582(581 aa)
|
未记录
|
GOL GLYCEROL × 6
SO4 SULFATE ION × 3
MN MANGANESE (II) ION × 2
CL CHLORIDE ION × 3
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293.15 K;Crystals originally grown in 15% PEG 1500, 0.1M MIB pH 4.2 (15mg/ml of SMP) were used to make seeds. Microseeded into a condition with a reservoir consisting of 17.8% PEG 3350, 136mM sodium sulfate with 1:10 dilution of seeds (7.5mg/ml of SMP) using a ratio of 200nl protein:133nl reservoir:67nl diluted seeds
|
分辨率 2.17 Å
R-free 0.226
|
|
7TVG
Crystal Structure of SHOC2 to a resolution of 2.4 Angstrom
提交 2022-02-04
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 D
59–564(506 aa)
|
未记录
|
SO4 SULFATE ION × 6
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293.15 K;1.5M ammonium sulfate, 0.1M sodium citrate pH 5.0
|
分辨率 2.40 Å
R-free 0.267
|
|
7TXH
Human MRas Q71R in complex with human Shoc2 LRR domain M173I and human PP1Ca
提交 2022-02-09
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 B
80–582(503 aa)
|
突变:M173I
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 6
MN MANGANESE (II) ION × 2
PO4 PHOSPHATE ION × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M NaH2PO4 pH 6.5, 12% PEG 8000
|
分辨率 1.95 Å
R-free 0.210
|
|
7TXH
Human MRas Q71R in complex with human Shoc2 LRR domain M173I and human PP1Ca
提交 2022-02-09
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 E
80–582(503 aa)
|
突变:M173I
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 10
MN MANGANESE (II) ION × 2
PO4 PHOSPHATE ION × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1 M NaH2PO4 pH 6.5, 12% PEG 8000
|
分辨率 1.95 Å
R-free 0.210
|
|
7TYG
Structure of the human leucine rich repeat protein SHOC2, residues 80-582
提交 2022-02-13
|
构建体不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
80–582(503 aa)
片段:residues 80-582
|
未记录
|
未记录非水小分子
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8;294 K;0.1M Tris-Cl(8.0), 0.2 M MgCl2, 11% PEG4K, 2.5% 1,5-diaminopentane
|
分辨率 1.90 Å
R-free 0.226
|
|
7TYG
Structure of the human leucine rich repeat protein SHOC2, residues 80-582
提交 2022-02-13
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 B
80–582(503 aa)
片段:residues 80-582
|
未记录
|
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8;294 K;0.1M Tris-Cl(8.0), 0.2 M MgCl2, 11% PEG4K, 2.5% 1,5-diaminopentane
|
分辨率 1.90 Å
R-free 0.226
|
|
7UPI
Cryo-EM structure of SHOC2-PP1c-MRAS holophosphatase complex
提交 2022-04-15
|
构建体不同
聚集状态不同
配体/离子不同
实验方法不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 C
1–582(582 aa)
|
未记录
|
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
MN MANGANESE (II) ION × 2
CL CHLORIDE ION × 1
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.4;Fluorinated octyl maltoside added immediately prior to vitrification
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 2.89 Å
|
|
9BTM
NRas 1-169 Q61R in Complex with Shoc2 80-582
提交 2024-05-15
|
构建体不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 B
80–582(503 aa)
|
未记录
|
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 7;295 K;0.1 M Hepes pH 7, 15% PEG 4000
|
分辨率 2.73 Å
R-free 0.238
|
|
9BTN
Structure of human SHOC2 in complex with a cyclic peptide
提交 2024-05-15
|
构建体不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 A
80–582(503 aa)
片段:residues 80-582
|
未记录
|
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;0.05 M Hepes pH 7.5, 35% v/v pentaerythritol propoxylate 5/4 PO/OH (PP 5/4 PO/OH), 0.2M KCl
|
分辨率 2.04 Å
R-free 0.252
|
|
9BTP
Structure of human SHOC2 in complex with a small molecule inhibitor (S)-5
提交 2024-05-15
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
80–582(503 aa)
片段:residues 80-582
|
未记录
|
A1ATZ (2S)-{2-[(4-chloro[1,1'-biphenyl]-3-yl)methoxy]phenyl}[(2-oxo-2,3-dihydro-1,3-benzoxazol-5-yl)amino]acetic acid × 1
K POTASSIUM ION × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;See reference. Crystals of apo SHOC2 in space group p212121 were incubated with compound and harvested. 50 mM Tris pH 7.0, 200 mM KCl, 40% PP 5/4 PO/OH
|
分辨率 2.37 Å
R-free 0.263
|
|
9O65
Cryo-EM structure of SHOC2-KRAS-PP1CA (SKP) complex
提交 2025-04-11
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验方法不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 A
1–582(582 aa)
|
突变:M173I
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
MN MANGANESE (II) ION × 2
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.4
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.00 Å
|
|
9OVJ
Structure of human SHOC2 in complex with a small molecule inhibitor (R)-5
提交 2025-05-30
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
80–582(503 aa)
片段:residues 80-582
|
未记录
|
A1CF1 (2R)-{2-[(4-chloro[1,1'-biphenyl]-3-yl)methoxy]phenyl}[(2-oxo-2,3-dihydro-1,3-benzoxazol-5-yl)amino]acetic acid × 1
K POTASSIUM ION × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 7;277 K;See reference. Crystals of apo SHOC2 in space group p212121 were incubated with compound and harvested. 0.05 M Tris (7.0), 40% (v/v) Pentaerythritol Propoxylate 5/4 PO/OH, 0.2 M KCl
|
分辨率 2.68 Å
R-free 0.275
|